Metabolic

Retatrutide

Investigational. Not an approved medicine. This listing is not a dosing guide.

An investigational triple-receptor agonist targeting GLP-1, GIP, and glucagon pathways. Clinical trials are evaluating substantial weight loss, metabolic health, and obesity-related conditions.

Vial size

CA$103

Estimated retail midpoint, CAD

• Code BC-16
• Form Research vial
• Category Metabolic

Research-use only. Not for human or veterinary administration. Availability depends on applicable regulations, including in Canada. Prices are estimates, not verified market averages. Descriptions are informational and do not imply Health Canada approval or proven clinical effectiveness. Many listed compounds are investigational or not authorized for human use in Canada.